We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Poultry Medicine/Pharmaceuticals Market: Growth, Size, Share, and Trends

Report Code MD 9278
Published in Jan, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029

Overview

The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching US$5.01 billion in 2024 and an impressive US$6.68 billion by 2029. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein. This growth in poultry medicine/production also brings with it the challenge of disease prevention and control as poultry is often attacked by diseases like Newcastle disease and coccidiosis. Enhanced consumer consciousness, safety concerns and strict law compliance towards the use of antibiotics in food animals have also influenced the market demand in that there is a high demand of vaccines, probiotics, and immune boosters as opposed to antibiotics. In addition to advancements in means of disease control growth enhancing products such as vaccines, in ovo vaccination technology geared towards delivery of vaccines has also worked to enhanced control of diseases among large scale farms. As such, with the emerging regions in Asia, Latin America and Africa increasing poultry production at an exponential rate, the market has also been enhancing towards supplying health solutions for healthy and productive farming dominantly in the sustainable manner.

Poultry Medicine/Pharmaceuticals Market– Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Poultry Medicine/Pharmaceuticals Market

Asia Pacific

Market growth in the Asia Pacific region can be attributed to increasing demand for poultry meat and eggs, urbanization advances and disposable income, outbreaks of poultry diseases with a focus on sustainability, safety, and innovation to meet the demands of a growing poultry industry.

With a growing population and increasing demand for poultry meat and eggs, especially in countries like China, India, and Japan, there's a surge in poultry farming. This increase naturally boosts the need for effective pharmaceuticals to manage poultry health.

Large poultry farms are emerging in countries like China, India, and Vietnam to meet rising demand. This expansion requires veterinary medicine/pharmaceuticals to maintain poultry health in densely populated farm environments.

The Asia Pacific market is expected to be worth USD 6.6 billion by 2029, growing at CAGR of 5.9 % during the forecast period.

As urbanization advances and disposable income rises across the region, especially in developing countries, the demand for quality animal protein, including poultry, grows. Consumers are more health-conscious and prefer safe, high-quality poultry products, leading to greater investment in health products for poultry.

Global Poultry Medicine/Pharmaceuticals Market Dynamics

DRIVER: Growing incidence of poultry disease

The poultry medicine/pharmaceuticals market is significantly driven by the growing incidence of poultry diseases, especially given that poultry breeds all over the globe face a myriad of infectious diseases Newcastle disease, Avian Influenza, Coccidiosis, Infectious Bronchitis, and many others. These challenges affect poultry farming since they may result in high mortality rates, decreased output, and large losses to poultry farmers. The boom in the poultry sector to meet up demand creates problems as the birds are kept very close to one another in this production system, thus disease prevention and control becomes very important. Consequently, there has been an increased use of vaccines, antibiotics, probiotic and other immunity enhancers by animal raisers, which helps prevent the disease outbreaks that would cause him/her lot of losses.

RESTRAINT: High cost of vaccine development

The vaccination of poultry takes time and effort as it is not an easy process. For such vaccines to be developed, there must be a lot of research, trial testing, and approval from the relevant authorities and all these aim at achieving the safety and effectiveness of the vaccines. These phases also require a lot of finances and technologies which in particular are hard to smaller pharmaceutical firms and start-up organizations penetrating into the market. Plus, there are extra expenses involved in running up production processes especially where the regulators have set high compliance risks standards for biosecurity as well as the regulators’ ostensible costs. These high costs of developing new products propensity translates to high prices for the final consumers which in this case becomes quite difficult for the poultry farmers especially those in emerging and low-margin economies to access new vaccines.

 

OPPORTUNITY: Growth in emerging markets

The market for poultry medicine/pharmaceuticals is mostly untapped in developing regions as the growth of poultry farming in these areas is fast spurred by urbanization, population changes as well as the growing need for affordable protein sources such as chicken and eggs. Poultry farming is attracting a lot of investment in Asia, Latin America and Africa due to the local demand for poultry supply and to enhance food security. Nevertheless, an increased surge in the use of vaccines, antibiotics, probiotics and other health products specific to these regions has emerged from the need to control diseases and biosecurity requirements. Moreover, considering regulatory agencies in these regions encouraging safer and more responsible farming without antibiotics, farmers have opted to use preventive and other alternative health methods. This trend is encouraging market growth which presents pharmaceutical companies with a lucrative platform to bring in new products and widen the existing range of products in these high growth markets.

CHALLENGES: Regulatory compliance

In the poultry medicine/pharmaceuticals market, the issue of regulatory compliance is a major one owing to the presence of diverse regional standards. Furthermore, governments and health authorities have made it mandatory to uphold stringent testing and safety and efficacy standards for poultry drugs, especially antibiotics which have been a target of scrutiny for their contribution to the overall antibacterial resistance problem. In an attempt to address the emerging concerns over use of antibiotics in poultry, Inland poultry health regulations of several nations also prohibit the use of several antibiotics or maintain them at reduced levels in food animals, which has led to pharmaceuticals developing other non-unsafe non antibiotic agents, like probiotics, vaccines and immune boosters. Complying with these changing regulations comes at a significant cost and takes a lot of time, since it involves research, reformulation and monitoring of the product's safety on a continual basis.

Global Poultry Medicine/Pharmaceuticals Market Ecosystem Analysis

Poultry Medicine/Pharmaceuticals Market
 

By animal type, chickens to be largest segment during forecast period

The poultry medicine/pharmaceuticals market is dominated by chickens mainly due to the availability of these protein source – chicken meat and egg, at affordable prices around the globe. This has, in turn, spurred the growth of chicken husbandry within the developing countries as their production quickly increases to satisfy the market. Chicks, on the other hand, are also exposed to many poultry illnesses that include Newcastle disease, Infectious bronchitis, and Eimeria coccidia which makes it vital to prevent any occurrences of diseases to ensure productivity and general welfare of the flock. As a result, the demand for vaccines, antibiotics and probiotics is higher in chickens compared to other forms of poultry. In addition to this, the enforcement of high food safety standards and biosecurity measures have also encouraged farms to implement preventive healthcare measures to manage the disease occurrence risk while providing services sustainably.

By products, vaccines to be largest segment during forecast period

Vaccines account for the largest share in the poultry medicine/pharmaceuticals market due to their vital role in preventing infectious diseases, which can cause catastrophic losses in poultry health and productivity. Given that poultry is vulnerable to Newcastle disease, Avian Influenza, and Infectious Bronchitis, among other diseases, vaccination programs are considered very important for the maintenance of flocks and to prevent economical losses for the producers. Increasingly, focus on food safety and pressure on regulatory consumers to reduce antibiotic use has pushed the demand for vaccines as the main instrument in preventing diseases. Innovation in vaccine delivery, for example through in ovo vaccination, has advanced the efficiency and efficacy of immunization, enabling massive poultry farms.

By disease indication, newcastle disease to be largest segment during forecast period

Newcastle disease account for the largest share in the poultry medicine/pharmaceuticals market since it poses significant economic and production challenges to the global poultry sector. It has a major effect on flock health due to high mortality rates, low productivity, and the imposition of trade restrictions upon outbreaks, considering that it is a highly infectious viral infection. The high and widespread acceptance of vaccines, such as live attenuated, inactivated, and recombinant vaccines, have been the most influential factors for this market segment. Additionally, the increased awareness of Newcastle Disease, governmental vaccination programs, and innovation in vaccine technologies like thermostable and vector-based solutions have placed Newcastle Disease high up on the poultry health management list.

By route of administration, oral route to be largest segment during forecast period

The orally delivered mode holds the largest share in the poultry medicine/pharmaceuticals market because of its ease of use, efficiency, and cost-effectiveness, especially for a large flock. Medication delivery via water or feed allows uniform distribution across the whole flock rather than labor-intensive, individual bird handling. It is also very applicable to a wide range of products, such as antibiotics, probiotics, vaccines, and nutritional supplements. Its use is therefore versatile in preventive and therapeutic applications. Oral administration is easy to scale, and therefore this method can be applied on large-scale poultry operations. Here, efficient disease management in maintaining healthy and productive flocks is required.

North America accounted for the largest share of the Poultry medicine/pharmaceuticals market in 2023.

The poultry medicine/pharmaceuticals market is dominated by North America because of its sophisticated poultry rearing infrastructures, high levels of poultry product consumption and strict measures for biosecurity and control of diseases. In this region, the practices of agriculture are geared towards making the use of antibiotics responsible, which is…” “encouraging the producers to use vaccines and other health intervention measures, rather than antibiotics for food production. Apart from the above, the enhancement of the market is attributable to the continuous investments towards research and the availability of modern management as well as curative practices of the diseases. Furthermore, the growing demand for sustainable and better efficient systems of poultry farming has also led to increased formulation of products geared towards enhancing health and productivity of the flocks thus ensuring that the North America remains at the top of the market.

HIGHEST CAGR MARKET IN 2024-2029
US FASTEST GROWING MARKET IN THE REGION
Poultry Medicine/Pharmaceuticals Market

Recent Developments of Poultry Medicine/Pharmaceuticals Market

  • In August 2024, Elanco announced a 25,000-square-foot expansion of its biologics manufacturing facility in Elwood, Kansas. The USD 130 million investment, set to be completed by 2026, will support the growth of its monoclonal antibody (mAb) platform.
  • In November 2023, Athian and Elanco Animal Health have partnered to reduce methane emissions in livestock farming, aiming to transform food production.
  • In March 2024, for their range of pet parasiticides, Boehringer Ingelheim India is happy to announce a strategic distribution agreement with Vvaan Lifesciences Private Limited.
  • In April 2024, Zoetis is selling its medicated feed additive (MFA) product portfolio, certain water-soluble products, and related assets to Phibro Animal Health. The deal also includes six manufacturing sites and over 300 employees and is expected to be completed in the second half of 2024.

Key Market Players

Want to explore hidden markets that can drive new revenue in Poultry Medicine/Pharmaceuticals Market?

Scope of the Report

Report Metric Details
Market size available for years 2024-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million/Billion)
Segments covered Animal Type, Product, Disease Indication, Route of Administration, and Region
Geographies covered North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, Australia, South Korea India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA (GCC Countries, RoMEA)

 

Key Questions Addressed by the Report

What is the expected addressable market value of the Poultry medicine/pharmaceuticals market over 5 years?
The poultry medicine/pharmaceuticals market is projected to reach USD 6.6 billion by 2029, at a CAGR of 5.9 % during the forecast period.
What are the key drivers for the Poultry medicine/pharmaceuticals market?
The poultry medicine/pharmaceuticals market is mainly driven by a few key factors, which are the ever-increasing demand for poultry products globally, especially in developing regions where chicken and eggs are the primary protein sources. Increased awareness about food safety and biosecurity has led to greater investments in disease prevention and management solutions, including vaccines and probiotics, to help mitigate risks associated with infectious diseases in poultry. With the regulatory pressures that enforce reduction in the use of antibiotics, there has been increased attention toward other drugs. This led to greater demand for innovative health products.
Which country/region occupies the largest share of the Poultry medicine/pharmaceuticals market, globally?
The largest share of the Poultry medicine/pharmaceuticals market is in Asia Pacific, owing to large-scale poultry farming motivated by rapid population growth, urbanization, and rising incomes in countries like China, India, and Indonesia. The various factors led to high production levels, thus there is a need for an efficient method of disease prevention and health management.
What are the strategies adopted by the top market players to penetrate emerging regions?
The major players in the market use partnerships, expansions, distribution agreements, product launches, and product approvals as important growth tactics.
What are the main players present in this market?
The main vendors in the market are include MSD (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva Sante Animale (France), Zoetis Service LLC (US), Virbac (France), Phibro Animal Health (US), Hester Biosciences Limited (India).

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Poultry Medicine/Pharmaceuticals Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
35
RESEARCH METHODOLOGY
39
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
58
MARKET OVERVIEW
62
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing poultry consumption
    - Growing incidence of poultry diseases
    - Advancements in poultry pharmaceuticals
    - Favorable initiatives by government agencies & animal welfare associations
    RESTRAINTS
    - High cost of vaccine development
    - Concerns associated with antibiotic resistance
    OPPORTUNITIES
    - High growth potential of emerging economies
    - Industrialization of poultry farming
    CHALLENGES
    - Stringent regulatory compliance for poultry pharmaceuticals
  • 5.3 INDUSTRY TRENDS
    ANTIBIOTIC-FREE SOLUTIONS
    EMERGENCE OF INNOVATIVE VACCINE TECHNOLOGIES
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - mRNA vaccines
    - Nanoparticle drug delivery
    - CRISPR gene editing
    COMPLEMENTARY TECHNOLOGIES
    - IoT-enabled health monitoring
    ADJACENT TECHNOLOGIES
    - Automated drug delivery systems
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - US
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    - North America
    - Europe
    - Rest of the World
  • 5.9 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR POULTRY PHARMACEUTICALS
  • 5.10 TRADE ANALYSIS
  • 5.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICALS, BY REGION (2022−2024)
    AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023)
  • 5.12 KEY CONFERENCES AND EVENTS, 2024−2025
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.14 UNMET NEEDS AND END-USER EXPECTATIONS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.15 ECOSYSTEM MARKET ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    CASE STUDY 1: MARKET DEVELOPMENT IN NIGER DELTA (MADE)
    CASE STUDY 2: JOURNEY OF TRIBAL WOMEN
    CASE STUDY 3: PROBLEMS & PROSPECTS OF POULTRY FARMING IN CHITTOOR, ANDHRA PRADESH
  • 5.17 ADJACENT MARKET ANALYSIS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI/GENAI ON POULTRY PHARMACEUTICALS MARKET
POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE
94
  • 6.1 INTRODUCTION
  • 6.2 CHICKEN
    BROILER
    - Specifically bred for high meat yield to drive market
    LAYER
    - Growing demand for eggs to fuel market
  • 6.3 TURKEY
    CONSUMER PREFERENCE FOR ORGANIC TURKEY BY-PRODUCTS TO DRIVE MARKET
  • 6.4 DUCK
    GROWING FOCUS ON DEVELOPMENT OF TARGETED VACCINES FOR DVH TO FUEL UPTAKE
  • 6.5 OTHER POULTRY
POULTRY PHARMACEUTICALS MARKET, BY PRODUCT
113
  • 7.1 INTRODUCTION
  • 7.2 DRUGS
    ANTIBIOTICS
    - Most widely used drug in poultry management to drive market
    ANTIPARASITICS
    - Ability to combat against coccidiosis and ectoparasites to boost demand
    ANTISEPTICS
    - Maintainance of biosecurity through infection reduction to fuel uptake
    NUTRITIONALS
    - Optimization of poultry health with enhanced productivity to support market growth
    OTHER DRUGS
  • 7.3 VACCINES
    LIVE-ATTENUATED VACCINES
    - Cost-efficiency and high efficacy benefits to fuel uptake
    INACTIVATED VACCINES
    - Pathogen carriers with high stability to drive market
    RECOMBINANT VACCINES
    - Ability to combat several avian diseases to boost demand
    OTHER VACCINES
  • 7.4 FEED ADDITIVES
    ADDITIONAL INCORPORATION TO DIETS FOR ENHANCED BENEFITS TO SUPPORT MARKET GROWTH
POULTRY PHARMACEUTICALS MARKET, BY DISEASE TYPE
150
  • 8.1 INTRODUCTION
  • 8.2 NEWCASTLE DISEASE
    INNOVATIONS IN NEXT-GEN VACCINES TO PROPEL MARKET
  • 8.3 INFECTIOUS BRONCHITIS
    HIGH MORTALITY CASES TO BOOST DEMAND
  • 8.4 INFECTIOUS BURSAL DISEASE
    GROWING DEMAND FOR MULTIVALENT VACCINES TO FUEL MARKET
  • 8.5 COCCIDIOSIS
    DEVELOPMENT OF ANTI-COCCIDIAL DRUGS TO FUEL UPTAKE
  • 8.6 SALMONELLA
    INCREASING INCIDENCE OF SALMONELLA OUTBREAKS TO DRIVE MARKET
  • 8.7 MAREK’S DISEASE
    GROWING FOCUS ON ENSURING FLOCK PRODUCTIVITY TO SUPPORT MARKET
  • 8.8 OTHER DISEASES
POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION
172
  • 9.1 INTRODUCTION
  • 9.2 ORAL ROUTE OF ADMINISTRATION
    HIGH UPTAKE OF ANTIBIOTICS DUE TO SCALABILITY AND COST-EFFICIENCY TO DRIVE MARKET
  • 9.3 INJECTABLE ROUTE OF ADMINISTRATION
    RAPID TREATMENT RESPONSE TO FUEL MARKET
  • 9.4 TOPICAL ROUTE OF ADMINISTRATION
    UPTAKE OF ANTIPARASITIC TREATMENT TO SUPPORT MARKET GROWTH
  • 9.5 OTHER ROUTES
POULTRY PHARMACEUTICALS MARKET, BY REGION
185
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Stringent regulatory protocols for disease prevention to drive market
    CANADA
    - Growing focus on animal health to drive market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing awareness of poultry health issues in Germany
    UK
    - Growing focus on antibiotic-free poultry to boost demand
    FRANCE
    - Avian influenza outbreaks and disease prevention strategies to fuel market growth
    SPAIN
    - Increased poultry production and export to drive market
    ITALY
    - Rising poultry trade and biosecurity measures to drive market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Focus on biosecurity and innovative pharmaceutical products to drive market
    CHINA
    - Increasing incidence of avian influenza to boost demand
    INDIA
    - Rapid expansion of poultry farming to fuel uptake
    AUSTRALIA
    - Growing focus on advanced pharmaceuticals to support market
    SOUTH KOREA
    - Frequent outbreak of coccidiosis to support market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Surge in poultry export to fuel uptake
    MEXICO
    - Increasing investments in broiler genetics to propel market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Expanding poultry sector to fuel uptake
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
328
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POULTRY PHARMACEUTICALS MARKET
  • 11.3 REVENUE ANALYSIS, 2019−2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Animal type footprint
    - Product footprint
    - Disease indication footprint
    - Route of administration footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
349
  • 12.1 KEY PLAYERS
    MERCK ANIMAL HEALTH (SUBSIDIARY OF MERCK & CO., INC.)
    - Business overview
    - Products offered
    - MnM view
    ELANCO
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CEVA SANTÉ ANIMALE
    - Business overview
    - Products offered
    - MnM view
    ZOETIS SERVICES LLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VIRBAC
    - Business overview
    - Products offered
    - Recent developments
    PHIBRO ANIMAL HEALTH CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    HESTER BIOSCIENCES LIMITED
    - Business overview
    - Products offered
    - Recent developments
    MEIJI ANIMAL HEALTH CO, LTD. (SUBSIDIARY OF K.M BIOLOGICS CO. LTD.)
    - Business overview
    - Products offered
    VENKY’S INDIA
    - Business overview
    - Products offered
    BIMEDA CORPORATE
    - Business overview
    - Products offered
    CALIER
    - Business overview
    - Products offered
    HIPRA
    - Business overview
    - Products offered
    VETANCO
    - Business overview
    - Products offered
    VAXXINOVA INTERNATIONAL BV
    - Business overview
    - Products offered
    BIOVAC GROUP
    - Business overview
    - Products offered
    KEMIN INDUSTRIES, INC.
    - Business overview
    - Products offered
    ?.L.KAR.-AGROZOOVET-SERVICE
    - Business overview
    - Products offered
    INDOVAX
    - Business overview
    - Products offered
    AVIMEX
    - Business overview
    - Products offered
  • 12.2 OTHER PLAYERS
    SYNTHÈSE ÉLEVAGE
    PROVET PHARMA PRIVATE LIMITED
    HUVEPHARMA
    ROMVAC COMPANY S.A.
    VMN PHARMACEUTICALS
APPENDIX
417
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 POULTRY PHARMACEUTICALS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 IMPACT ANALYSIS OF PORTER’S FIVE FORCES
  • TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LIST OF PATENTS IN POULTRY PHARMACEUTICALS MARKET, 2022–2024
  • TABLE 8 IMPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICAL PRODUCTS, BY REGION (2022−2024)
  • TABLE 11 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023) (USD)
  • TABLE 12 POULTRY PHARMACEUTICALS MARKET: KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • TABLE 14 KEY BUYING CRITERIA FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • TABLE 15 END-USER EXPECTATIONS FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • TABLE 16 POULTRY PHARMACEUTICALS MARKET: ECOSYSTEM ANALYSIS
  • TABLE 17 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 18 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 19 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 20 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 21 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 22 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 23 BROILER PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 24 BROILER PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 25 LAYER PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 26 LAYER PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 27 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 28 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 29 DUCK PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 30 DUCK PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 31 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 32 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 33 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 34 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 35 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 36 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 37 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 38 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 39 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 40 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 41 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 42 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 43 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 44 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 45 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 46 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 47 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 48 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 49 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 50 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 51 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 52 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 53 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 54 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 55 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 56 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 57 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 58 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 59 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 60 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 61 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 62 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 63 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 64 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 65 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 66 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 67 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 68 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 69 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 70 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 71 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 72 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 73 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 74 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 75 POULTRY PHARMACEUTICALS MARKET FOR MAREK’S DISEASE, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 76 POULTRY PHARMACEUTICALS MARKET FOR MAREK’S DISEASE, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 77 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 78 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 79 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 80 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 81 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 82 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 83 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 84 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 85 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 86 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 87 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 88 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 89 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 90 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
  • TABLE 92 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 94 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 96 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 98 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 100 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 102 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 104 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 106 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 107 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 108 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 109 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 110 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 111 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 112 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 113 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2019–2022 (USD MILLION)
  • TABLE 114 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2023–2029 (USD MILLION)
  • TABLE 115 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 116 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 117 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 118 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 119 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 120 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 121 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 122 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 123 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 124 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 125 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 126 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 127 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 128 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 129 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 130 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 131 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 132 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 133 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 134 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 135 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
  • TABLE 136 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 137 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 138 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 139 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 140 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 141 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 142 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 143 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 144 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 145 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 146 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 147 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 148 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 149 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 150 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 151 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 152 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 153 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 154 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 155 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 156 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 157 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2019–2022 (USD MILLION)
  • TABLE 158 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2023–2029 (USD MILLION)
  • TABLE 159 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 160 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 161 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 162 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 163 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 164 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 165 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 166 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 167 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 168 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 169 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 170 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 171 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 172 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 173 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 174 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 175 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 176 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 177 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 178 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 179 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 180 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 181 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 182 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 183 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 184 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 185 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 186 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 187 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 188 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 189 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 190 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 191 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 192 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 193 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 194 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 195 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 196 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 197 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 198 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 199 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 200 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 201 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 202 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 203 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 204 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 205 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 206 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 207 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 208 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 209 ITALY: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 210 ITALY: CHICEKN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 211 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 212 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 213 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 214 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 215 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 216 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 217 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 218 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 219 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 220 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 221 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 222 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 223 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 224 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 225 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 226 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 227 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 228 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 229 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 230 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 231 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 232 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 233 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 234 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 251 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 252 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 253 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 254 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 255 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 256 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 257 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 258 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 259 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 260 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 261 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 262 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 263 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 264 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 265 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 266 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 267 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 268 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 269 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 270 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 271 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 272 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 273 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 274 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 275 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 276 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 277 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 278 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 279 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 280 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 281 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 282 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 283 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 284 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 285 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 286 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 287 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 288 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 289 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 290 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 291 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 292 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 293 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 294 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 295 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 296 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 297 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 298 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 299 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 300 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 301 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 302 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 303 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 304 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 305 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 306 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 307 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 308 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 309 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 310 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 311 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 312 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 313 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 314 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 315 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 316 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 317 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 318 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 319 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 320 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 321 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 322 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 323 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 324 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 325 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 326 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 327 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 328 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 329 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 330 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 331 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 332 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 333 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 334 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 335 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019–2022 (USD MILLION)
  • TABLE 336 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 338 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 339 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 340 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 341 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 342 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 343 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 344 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 345 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 346 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 348 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 349 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 350 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 351 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 352 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 353 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 354 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 355 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 356 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 357 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 358 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 359 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 360 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 361 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 362 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 363 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 364 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 365 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 366 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 367 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 368 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 369 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 370 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 371 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 372 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 373 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 374 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 375 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 376 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 377 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 378 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 381 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 382 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 383 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 384 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 385 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 386 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 387 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 388 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 389 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 390 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 391 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 392 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 393 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 395 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 396 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 397 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 398 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 399 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 400 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 401 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 402 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 403 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 404 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 405 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 406 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 409 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 410 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 411 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 412 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 413 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 414 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 415 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 416 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 419 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 421 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 423 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
  • TABLE 424 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
  • TABLE 425 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 426 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 427 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
  • TABLE 428 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
  • TABLE 429 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 430 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 431 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
  • TABLE 432 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 433 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
  • TABLE 434 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
  • TABLE 435 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
  • TABLE 436 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
  • TABLE 437 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 438 POULTRY PHARMACEUTICALS MARKET: DEGREE OF COMPETITION
  • TABLE 439 POULTRY PHARMACEUTICALS MARKET: REGION FOOTPRINT
  • TABLE 440 POULTRY PHARMACEUTICALS MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 441 POULTRY PHARMACEUTICALS MARKET: PRODUCT FOOTPRINT
  • TABLE 442 POULTRY PHARMACEUTICALS MARKET: DISEASE INDICATION FOOTPRINT
  • TABLE 443 POULTRY PHARMACEUTICALS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
  • TABLE 444 POULTRY PHARMACEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 445 POULTRY PHARMACEUTICALS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 446 POULTRY PHARMACEUTICALS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−NOVEMBER 2024
  • TABLE 447 POULTRY PHARMACEUTICALS MARKET: DEALS, JANUARY 2021−NOVEMBER 2024
  • TABLE 448 POULTRY PHARMACEUTICALS MARKET: EXPANSIONS, JANUARY 2021−NOVEMBER 2024
  • TABLE 449 POULTRY PHARMACEUTICALS MARKET: OTHER DEVELOPMENTS, JANUARY 2021−NOVEMBER 2024
  • TABLE 450 MERCK ANIMAL HEALTH: COMPANY OVERVIEW
  • TABLE 451 MERCK ANIMAL HEALTH: PRODUCTS OFFERED
  • TABLE 452 ELANCO: COMPANY OVERVIEW
  • TABLE 453 ELANCO: PRODUCTS OFFERED
  • TABLE 454 ELANCO: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 455 ELANCO: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 456 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 457 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 458 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT APPROVALS, JANUARY 2021– NOVEMBER 2024
  • TABLE 459 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2021– NOVEMBER 2024
  • TABLE 460 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: EXPANSIONS, JANUARY 2021– NOVEMBER 2024
  • TABLE 461 CEVA SANTÉ ANIMALE: COMPANY OVERVIEW
  • TABLE 462 CEVA SANTÉ ANIMALE: PRODUCTS OFFERED
  • TABLE 463 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 464 ZOETIS SERVICES LLC: PRODUCTS OFFERED
  • TABLE 465 ZOETIS SERVICES LLC: JANUARY 2021–NOVEMBER 2024
  • TABLE 466 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 467 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 468 VIRBAC: COMPANY OVERVIEW
  • TABLE 469 VIRBAC: PRODUCTS OFFERED
  • TABLE 470 VIRBAC: DEALS, JANUARY 2021– NOVEMBER 2024
  • TABLE 471 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY OVERVIEW
  • TABLE 472 PHIBRO ANIMAL HEALTH CORPORATION: PRODUCTS OFFERED
  • TABLE 473 PHIBRO ANIMAL HEALTH CORPORATION: DEALS, JANUARY 2021– NOVEMBER 2024
  • TABLE 474 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW
  • TABLE 475 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED
  • TABLE 476 HESTER BIOSCIENCES LIMITED: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 477 MEIJI ANIMAL HEALTH CO., LTD.: COMPANY OVERVIEW
  • TABLE 478 MEIJI ANIMAL HEALTH CO., LTD.: PRODUCTS OFFERED
  • TABLE 479 VENKY’S INDIA: COMPANY OVERVIEW
  • TABLE 480 VENKY’S INDIA: PRODUCTS OFFERED
  • TABLE 481 BIMEDA CORPORATE: COMPANY OVERVIEW
  • TABLE 482 BIMEDA CORPORATE: PRODUCTS OFFERED
  • TABLE 483 CALIER: COMPANY OVERVIEW
  • TABLE 484 CALIER: PRODUCTS OFFERED
  • TABLE 485 HIPRA: COMPANY OVERVIEW
  • TABLE 486 HIPRA: PRODUCTS OFFERED
  • TABLE 487 VETANCO: COMPANY OVERVIEW
  • TABLE 488 VETANCO: PRODUCTS OFFERED
  • TABLE 489 VAXXINOVA INTERNATIONAL BV: COMPANY OVERVIEW
  • TABLE 490 VAXXINOVA INTERNATIONAL BV: PRODUCTS OFFERED
  • TABLE 491 BIOVAC GROUP: COMPANY OVERVIEW
  • TABLE 492 BIOVAC GROUP: PRODUCTS OFFERED
  • TABLE 493 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 494 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED
  • TABLE 495 ?.L.KAR.-AGROZOOVET-SERVICE: COMPANY OVERVIEW
  • TABLE 496 ?.L.KAR.-AGROZOOVET-SERVICE: PRODUCTS OFFERED
  • TABLE 497 INDOVAX: COMPANY OVERVIEW
  • TABLE 498 INDOVAX: PRODUCTS OFFERED
  • TABLE 499 AVIMEX: COMPANY OVERVIEW
  • TABLE 500 AVIMEX: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 MARKET & REGIONAL SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MERCK ANIMAL HEALTH (2023)
  • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: POULTRY PHARMACEUTICALS MARKET (2023)
  • FIGURE 10 MARKET SIZE ESTIMATION: DEMAND ANALYSIS
  • FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2023–2029)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF POULTRY PHARMACEUTICALS MARKET
  • FIGURE 19 INCREASING POULTRY CONSUMPTION TO PROPEL MARKET
  • FIGURE 20 VACCINES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 21 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 24 POULTRY PHARMACEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE
  • FIGURE 26 POULTRY PHARMACEUTICALS MARKET SUPPLY CHAIN ANALYSIS
  • FIGURE 27 POULTRY PHARMACEUTICALS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2014–SEPTEMBER 2024)
  • FIGURE 29 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR POULTRY PHARMACEUTICALS (JANUARY 2014–SEPTEMBER 2024)
  • FIGURE 30 TOP APPLICANT JURISDICTIONS FOR POULTRY PHARMACEUTICAL PATENTS (JANUARY 2014–SEPTEMBER 2024)
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • FIGURE 32 KEY BUYING CRITERIA FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • FIGURE 33 POULTRY PHARMACEUTICALS MARKET: END-USER EXPECTATIONS
  • FIGURE 34 POULTRY PHARMACEUTICALS MARKET: ECOSYSTEM MARKET MAP
  • FIGURE 35 ADJACENT MARKETS OF POULTRY PHARMACEUTICALS MARKET
  • FIGURE 36 INVESTMENT/VENTURE CAPITAL SCENARIO IN POULTRY PHARMACEUTICALS MARKET, 2019–2022
  • FIGURE 37 POULTRY PHARMACEUTICALS MARKET: GEOGRAPHIC SNAPSHOT (2024–2029)
  • FIGURE 38 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN POULTRY PHARMACEUTICALS MARKET (2019−2023)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY PHARMACEUTICALS MARKET (2023)
  • FIGURE 42 POULTRY PHARMACEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 POULTRY PHARMACEUTICALS MARKET: COMPANY FOOTPRINT
  • FIGURE 44 POULTRY PHARMACEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 POULTRY PHARMACEUTICALS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 MERCK & CO., INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 49 ELANCO: COMPANY SNAPSHOT (2023)
  • FIGURE 50 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2023)
  • FIGURE 52 VIRBAC: COMPANY SNAPSHOT (2023)
  • FIGURE 53 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 54 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 55 MEIJI ANIMAL HEALTH CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 VENKY’S INDIA: COMPANY SNAPSHOT (2023)

The study involved four major activities to estimate the current size of the Poultry medicine/pharmaceuticals market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Poultry medicine/pharmaceuticals market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the Poultry medicine/pharmaceuticals market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Poultry medicine/pharmaceuticals market.; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents:

Poultry Medicine/Pharmaceuticals Market

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue.

As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the poultry medicine/pharmaceuticals market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Poultry medicine/pharmaceuticals market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Poultry medicine/pharmaceuticals market was obtained from secondary data and validated by primary participants to arrive at the total Poultry medicine/pharmaceuticals market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Poultry medicine/pharmaceuticals market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Poultry medicine/pharmaceuticals market Size: Bottom -Up Approach & Top – down approach

Poultry Medicine/Pharmaceuticals Market

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Poultry medicine/pharmaceuticals market.

Market Definition

Poultry medicine/pharmaceuticals – these are medicinal preparations that are primarily used for prophylaxis, therapy, and disease management in birds reared for meat or eggs or for breeding, such as chickens, turkeys, ducks, and other avian pets. This group consists of vaccines, antibiotics, anti-parasites, probiotics, and immune-stimulants which are intended for the treatment or prevention of poultry diseases, growth promotion, and food safety. Poultry medicine/pharmaceuticals have taken over the socio-economic aspects of poultry farming and agriculture for that matter in fighting diseases, increasing yields, and helping in the maintenance of hygiene and health standards in the production system without the use of excessive stress on antibiotics.

Stakeholders

  • Animal vaccine manufacturers
  • Poultry healthcare product manufacturers
  • Animal vaccine distributors and wholesalers
  • Animal welfare associations
  • Veterinary clinics and care centers
  • Research and consulting firms
  • Research institutes
  • Contract research organizations
  • Feed Manufacturers
  • Poultry Farmers
  • Contract manufacturing organizations
  • Venture capitalists

Report Objectives

  • To define, describe, segment, and forecast the global Poultry medicine/pharmaceuticals market by types and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Poultry medicine/colpharmaceuticals market.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the Poultry medicine/pharmaceuticals market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the global Poultry medicine/pharmaceuticals market and comprehensively analyze their core competencies2 and market shares.
  • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
  • To benchmark players within the Poultry medicine/pharmaceuticals market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Poultry Medicine/Pharmaceuticals Market

DMCA.com Protection Status